THE HIDDEN WORK BEHIND SCIENTIFIC PROGRESS: WHY PRIVATE PHILANTHROPY STILL MATTERS
- Margarita Kilpatrick
- 1 minute ago
- 2 min read
Most people only see the breakthroughs. The new drug. The novel therapy. The press release.
But what they don’t see is the grind behind the scenes. The years of effort, the research that doesn’t get funded, and the scientists struggling to keep momentum without institutional support.
This is the space where private philanthropy makes the difference.

THE GAP BETWEEN POTENTIAL AND PROGRESS
Federal agencies like NIH play a vital role in driving research, but they’re also constrained.
Constrained by politics. By funding cycles. By consensus. By the weight of bureaucracy. And that means high-potential ideas, especially the ones that are early-stage, contrarian, or outside the mainstream, often don’t get a shot.
At the JKTG Foundation, we’ve seen this firsthand. Some of the most promising cancer research we’ve supported was previously passed over for traditional funding. Not because it lacked merit, but because it didn’t fit neatly into the established mold.
Philanthropy stepped in not to replace public dollars, but to go where they couldn’t.
BUILDING TRUST WITH THE RIGHT RESEARCHERS
Philanthropy only works when you trust the people doing the work.
At JKTG, we don’t fund ideas blindly. We fund people we believe in. Researchers who are curious, committed, and ready to challenge assumptions. We’ve built long-standing relationships with scientists across institutions like Johns Hopkins, Stanford, and Weill Cornell, not because of name recognition, but because of the integrity and imagination they bring to the work.
Private funding gives them something rare: flexibility. The freedom to pursue new questions. To take risks. To push science forward without waiting on a bureaucratic green light.
IT’S NOT GLAMOROUS, BUT IT’S NECESSARY
We don’t fund things because they’re flashy. We fund what we believe is useful.
That includes research on tumor microenvironments, translational cell biology, and immune response modulation, critical areas that don’t always capture headlines, but lay the groundwork for everything that comes next.
We’re not interested in chasing buzzwords. We’re here to make the hard work possible.
LEGACY ISN’T ABOUT BUILDINGS. IT’S ABOUT MOMENTUM.
When people think about legacy, they often think about names on buildings or plaques in lobbies.
But real legacy in science is momentum. It’s the work that keeps going. The minds you helped develop. The collaborations you sparked. The questions you helped raise before the answers were obvious.
That’s what drives our philanthropy. Not the spotlight, but the spark.
WHY THIS STILL MATTERS IN 2026
Science isn’t slowing down. But funding gaps are growing wider.
AI tools are accelerating what’s possible. Global health systems are under pressure. And the cost of inaction in research is steeper than ever. Private philanthropy isn’t a luxury. It’s an essential part of a balanced research ecosystem.
When foundations like ours show up, consistently, quietly, it creates a ripple effect. The right study gets done. The right collaboration gets funded. The next generation of scientists gets mentored.
We’re not trying to solve everything. But we are committed to making sure good science doesn’t stall because it didn’t fit a government rubric. And that’s a role I’ll always be proud to play.



